{"id":"placebo-slurry","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo effects operate via psychological and neurobiological pathways, including expectation-driven activation of endogenous neurotransmitter systems and pain modulation circuits. The slurry formulation is an inert preparation designed to be administered as a control or comparative agent in clinical research. In marketed contexts, any therapeutic benefit derives from placebo response rather than active pharmacological mechanisms.","oneSentence":"Placebo slurry produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous healing mechanisms.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:01:21.766Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control agent in clinical trials"}]},"trialDetails":[{"nctId":"NCT04013555","phase":"PHASE1, PHASE2","title":"The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-01-20","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":88},{"nctId":"NCT06151782","phase":"NA","title":"Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2024-01-01","conditions":"Celiac Disease, Food Intolerance","enrollment":33},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT06242444","phase":"NA","title":"An Erosion Study to Investigate the Efficacy of an Experimental Dentifrice to Remineralize Enamel","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-02-26","conditions":"Tooth Erosion","enrollment":33},{"nctId":"NCT01632202","phase":"PHASE4","title":"Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2012-05","conditions":"Intrauterine Adhesions","enrollment":11},{"nctId":"NCT03296072","phase":"PHASE3","title":"In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-11-13","conditions":"Tooth Erosion","enrollment":62},{"nctId":"NCT02019758","phase":"PHASE4","title":"Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-01-01","conditions":"Eosinophilic Esophagitis","enrollment":129},{"nctId":"NCT03716388","phase":"PHASE3","title":"Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC","status":"UNKNOWN","sponsor":"Dayanand Medical College and Hospital","startDate":"2018-12-01","conditions":"Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate","enrollment":20},{"nctId":"NCT00751257","phase":"PHASE2","title":"N-Acetylcysteine and Smoking Reduction","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2006-12","conditions":"Nicotine Dependence","enrollment":33},{"nctId":"NCT00770991","phase":"PHASE1","title":"Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2005-12","conditions":"Familial Adenomatous Polyposis","enrollment":34},{"nctId":"NCT00708305","phase":"PHASE3","title":"Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-06","conditions":"Dental Caries","enrollment":65},{"nctId":"NCT00762450","phase":"PHASE3","title":"Effect on Bacterial Glycolytic Acid Formation on Plaque","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2008-04","conditions":"Dental Plaque","enrollment":6},{"nctId":"NCT00644293","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Pharyngitis, Tonsillitis","enrollment":598},{"nctId":"NCT00644449","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Bronchitis, Chronic","enrollment":551},{"nctId":"NCT00643409","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Maxillary Sinusitis","enrollment":541},{"nctId":"NCT00643734","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-04","conditions":"Pneumonia","enrollment":468}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sucralose"],"phase":"marketed","status":"active","brandName":"Placebo slurry","genericName":"Placebo slurry","companyName":"University of North Carolina, Chapel Hill","companyId":"university-of-north-carolina-chapel-hill","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo slurry is an intervention used in clinical trials for various conditions, including Ulcerative Colitis, Celiac Disease, and Familial Adenomatous Polyposis. It is used as a control group in studies comparing it to other interventions, such as Fecal Microbiota Transplantation and Mesalamine Granules.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}